Preferred Label : norfloxacin;

MeSH definition : A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.;

CISMeF synonym : merck brand of norfloxacin; norfloxacin merck brand;

MeSH hyponym : noroxin; AM-0715; MK-0366; MK 0366; MK-366; MK 366; MK0366; MK366; AM 0715; AM0715; AM-715; AM 715;

MeSH CAS label : 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-;

MeSH Related Number : 70458-96-7 (Norfloxacin);

Registry Number MeSH : 70458-96-7;

Wikipedia link : https://en.wikipedia.org/wiki/Norfloxacin;

Codes EINECS : 274-614-4;

Is substance : O;

UNII : N0F8P22L1P;

InChIKey : OGJPXUAPXNRGGI-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.

https://www.has-sante.fr/jcms/p_3434791/fr/norfloxacine-zentiva-norfloxacine-infections-gastro-intestinales
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
ascitic fluid
liver cirrhosis
anti-bacterial agents
norfloxacin
antibiotic prophylaxis
Ascites infection
evaluation of the transparency committee
norfloxacin

---
https://sante.fr/norfloxacine-1
2019
false
false
false
France
French
patient education handout
norfloxacin
norfloxacin
anti-bacterial agents

---
https://www.has-sante.fr/portail/jcms/c_2842329/fr/generiques-de-noroxine
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
insurance, health, reimbursement
administration, oral
anti-bacterial agents
norfloxacin
bacterial urogenital infection
norfloxacin

---
http://www.has-sante.fr/portail/jcms/c_2730824/fr/chibroxine
2016
false
false
false
France
French
evaluation of the transparency committee
norfloxacin

---
http://www.infectiologie.com/UserFiles/File/medias/Recos/2015-MAP-fluoroquinolones-SPILF.pdf
http://www.infectiologie.com/UserFiles/File/medias/diaporamas/recos/SPILF-groupe_reco-SPILF-FQ-2015.pptx
2015
true
false
false
France
French
guidelines for drug use
osteoarticular infections
ciprofloxacin
levofloxacin
norfloxacin
anti-bacterial agents
pefloxacin
ofloxacin
diabetic foot
Diabetic foot infection
pyelonephritis
urinary tract infections
Q fever
legionellosis
anthrax
anthrax
plague
plague
tularemia
tularemia
gonorrhea
community-acquired infections
pneumonia, bacterial
Nosocomial pneumonia
Community acquired pneumonia
cross infection
maxillary sinusitis
meningitis, bacterial
antibiotic prophylaxis
fluoroquinolones
fluoroquinolones
drug resistance, bacterial
Intestinal Flora
diarrhea
typhoid fever
Ascites infection
intraabdominal infections
mycobacterium infections
reproductive tract infections
child
adult
aged
antibiotic therapy
aza compounds
quinolines
Moxifloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68852180
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64754454
2012
France
summary of product characteristics
package leaflet
norfloxacin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60110782
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67291972
2012
France
summary of product characteristics
package leaflet
norfloxacin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61574294
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69563150
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69005170
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65616470
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64700759
2012
France
summary of product characteristics
package leaflet
norfloxacin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68557867
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62866052
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://www.has-sante.fr/portail/jcms/c_1332083/chibroxine
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/chibroxine_17102012_avis_ct11687.pdf
http://www.has-sante.fr/portail/jcms/c_455268/chibroxine
2012
France
French
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
administration, ophthalmic
ophthalmic solutions
anti-bacterial agents
conjunctivitis, bacterial
keratitis
corneal ulcer
eye infections, bacterial
norfloxacin
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61062600
2012
France
summary of product characteristics
package leaflet
ophthalmic solutions
eyedrops
norfloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69894392
2012
France
summary of product characteristics
package leaflet
tablets
norfloxacin

---
http://www.has-sante.fr/portail/jcms/c_751115/noroxine
2009
France
evaluation of the transparency committee
norfloxacin

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.